Segra International Corp., an agriculture technology company, announced the approval of its Analytical Testing License from Health Canada under the Cannabis Act and Cannabis Regulations.
Segra’s Molecular Lab opened in 2017 to provide pathogen diagnostic testing and cultivar identification services for the company’s tissue culture facility. These services have become a critical part of the quality assurance process that underlays its Verified Clean Stock program, and now includes ten Real Time PCR-based plant pathogen assays, including for HLVd. Having in-house molecular testing services is an important differentiator for Segra and provides its customers with peace of mind that they receive heathy, true to type, disease-free plantlets. After performing nearly 10,000 assays in the 2021-2022 fiscal year, the company has upgraded its lab to increase capacity and now offer these services to its customers and other third parties looking for better crop surveillance tools.
"We have been using Segra's molecular lab for internal purposes and after feedback from customers, it’s time to make these value-added services available for all LPs in an effort to help mitigate cultivation risks, increase supply chain security and to monitor your fungal pathogen, virus and viroid load, all standard best practices in other commercially grown crops." stated Jamie Blundell, CEO of Segra.
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo: Benzinga edit with photos by jarmoluk and lindsayfox on Pixabay
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
